Advertisement
News
Subscribe to MDT Magazine News

Southampton scientists begin patient trials of new leukemia cancer vaccine

January 31, 2011 8:39 am | by EurekAlert | Comments

(University of Southampton) A new cancer treatment which strengthens a patient's immune system and enables them to fight the disease more effectively is being trialled on patients for the first time in the UK.

TOPICS:

Boston Scientific's Renegade device gets FDA nod

January 31, 2011 8:34 am | Comments

The U.S. Food and Drug Administration has approved Boston Scientific Corp.'s Renegade HI-FLO Fathom Pre-Loaded System, developed to treat uterine fibroids and liver cancer.

DNA Direct Announces New Health Plan Clients Managing Molecular Diagnostic and Genetic Tests

January 31, 2011 7:33 am | by Bio-Medicine.Org | Comments

SAN FRANCISCO, Jan. 31, 2011 /- DNA Direct, a wholly owned subsidiary of Medco Health Solutions, Inc. (NYSE: MHS ) and a provider of guidance and decision support for genomic medicine, today announced four new health plan clients that are implementing DNA Direct's Policy & Benefit...

TOPICS:
Advertisement

ImaginAb, Inc. and Eurogentec S.A. Collaborate to Produce Antibody Fragments in Pichia

January 31, 2011 7:32 am | by Bio-Medicine.Org | Comments

LOS ANGELES, Jan. 31, 2011 /- ImaginAb, Inc. and Eurogentec S.A. announce a development collaboration to establish a novel system for producing engineered antibody fragments. The two companies will produce ImaginAb's optimized antibody fragments with Eurogentec's high-performance Pichia...

TOPICS:

Covidien, Massimo extend royalty deal for 3 years

January 31, 2011 5:45 am | by The Associated Press | Comments

Medical device and drug maker Covidien PLC said Monday it extended a royalty agreement with medical technology company Masimo Corp. for its pulse oximetry products — devices that monitor oxygen in the bloodstream — sold in the United States.Covidien, which is based in Ireland, will pay Masimo, of...

PDI to Present at the UBS 21st Annual Global Healthcare Services Conference

January 31, 2011 5:36 am | by Bio-Medicine.Org | Comments

PARSIPPANY, N.J., Jan. 31, 2011 /- PDI, Inc. (Nasdaq: PDII ) today announced that Nancy Lurker, the company's chief executive officer, is scheduled to present at the UBS 21st Annual Global Healthcare Services Conference at 3:30 pm ET on February 8, 2011 at the Grand Hyatt New York. The...

TOPICS:

Qforma, Leading Provider of Healthcare Analytics, Announces Three New Appointments

January 31, 2011 5:35 am | by Bio-Medicine.Org | Comments

SANTA FE, N.M. and PRINCETON, N.J., Jan. 31, 2011 /- Qforma, the leading provider of advanced analytics and predictive modeling technologies for the health sciences industry, today announced the appointments of Ted Pine and Devon Reimer as Vice Presidents of Business Development, and...

TOPICS:

Bayer Animal Health Announces the Launch of Advantage® II and K9 Advantix® II

January 31, 2011 5:35 am | by Bio-Medicine.Org | Comments

SHAWNEE, Kan., Jan. 31, 2011 /- Bayer Animal Health announced this month at the North American Veterinary Conference, the availability of its new products:  Advantage® II for cats and dogs, and K9 Advantix® II for dogs.  These products combine the adulticidal...

TOPICS:
Advertisement

Amarin Provides 2010 Year-End Review to Shareholders

January 31, 2011 5:35 am | by Bio-Medicine.Org | Comments

DUBLIN and MYSTIC, Conn., Jan. 31, 2011 /- Amarin Corporation plc (Nasdaq: AMRN ), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today issued a special letter to its shareholders. The text of the letter, written by Joseph S. Zakrzewski, Executive...

TOPICS:

ClinOps to Change Name to Emphusion

January 31, 2011 5:35 am | by Bio-Medicine.Org | Comments

SAN FRANCISCO, Jan. 31, 2011 /- ClinOps is a specialized contract research organization with a core service offering combining expert data management, biostatistics and specialized clinical services. Emphusion targets development programs in biotechnology, medical device, and...

TOPICS:

Laureate Pharma Changes Name to Laureate Biopharmaceutical Services, Inc.

January 31, 2011 5:35 am | by Bio-Medicine.Org | Comments

PRINCETON, N.J., Jan. 31, 2011 /- Laureate Pharma, Inc. has changed its name to Laureate Biopharmaceutical Services, Inc. (Laureate Biopharma) to better describe the company's positioning in the biopharmaceutical industry.  The company's logo has been updated to emphasize "Laureate"...

TOPICS:

Endologix Announces Favorable Clinical Results for Nellix Technology

January 31, 2011 5:34 am | by Bio-Medicine.Org | Comments

IRVINE, Calif., Jan. 31, 2011 /- Endologix, Inc. (Nasdaq: ELGX ), developer of minimally invasive treatments for aortic disorders, announced today the publication of favorable clinical results for the Nellix technology for the endovascular repair of abdominal aortic aneurysm (EVAR)....

TOPICS:

Mederi Therapeutics Announces Receipt of FDA 510(k) Clearance for the MDRF1 Radiofrequency Generator

January 31, 2011 5:34 am | by Bio-Medicine.Org | Comments

GREENWICH, Conn., Jan. 31, 2011 /- Mederi Therapeutics Inc. announced today that it has received FDA 510(k) clearance for its new MDRF1 Generator. The Mederi RF Generator powers the Stretta® System for treatment of Gastroesophageal Reflux Disease (GERD) as well as the Secca®...

TOPICS:

Johnson & Johnson Recall of DePuy Hip Devices: Lewitt Hackman Files Suit

January 31, 2011 5:34 am | by Bio-Medicine.Org | Comments

LOS ANGELES, Jan. 31, 2011 /- Attorneys at Lewitt, Hackman, Shapiro, Marshall & Harlan, a southern California law firm, filed a lawsuit regarding a Johnson & Johnson recall of DePuy metal on metal hip replacement devices. The firm filed the suit against DePuy Orthopedics, Inc. and...

TOPICS:

Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System

January 31, 2011 5:33 am | by Bio-Medicine.Org | Comments

NATICK, Mass., Jan. 31, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced that the U.S. Food and Drug Administration (FDA) has approved its Renegade® HI-FLO™ Fathom® Pre-Loaded System for selective access and delivery of diagnostic, embolic and therapeutic...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading